Sandoz launches ustekinumab biosimilar in Europe
Sandoz launched the biosimilar of J&J’s Stelara in Europe in partnership with Samsung Bioepis to treat psoriasis and Crohn’s disease.
Biopharmaceutical Industry
Lilly bolsters IBD portfolio with $3.2bn Morphic acquisition
Pharma M&A: The top high value deals in 2023
Alimera Sciences shares jump by 77% after being acquired by ANI
Takeda signs option agreement with Ascentage for CML drug
Moderna and Myrtelle among those picked for FDA rare disease programme
Lilly strikes deal with QurAlis for preclinical ALS candidate
Dupixent gets closer to EU approval as the FDA delays its decision on COPD
